Compound Detail
CHEMBL267936
MECAMYLAMINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL267936 |
| Name | MECAMYLAMINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | IMYZQPCYWPFTAG-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
10
Targets
21
Activities
3
Assay Types
0
PK Parameters
20
Publications
2
Known Names
10
Indications
Molecular Properties
167.3
MW (Da)
2.42
ALogP
1
HBA
1
HBD
12.0
PSA (Ų)
0.63
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1956 |
| Availability | Prescription |
| Chirality | Racemic |
Indications
Hypertension Alcoholism Depressive Disorder, Major Macular Degeneration Macular Degeneration Tobacco Use Disorder Aging Autistic Disorder Child Development Disorders, Pervasive Cognitive Dysfunction
ATC Classification
C02BB01
mecamylamine
Level 1: CARDIOVASCULAR SYSTEM
Level 2: ANTIHYPERTENSIVES
Activity Summary
IC50 18 meas. best 7.0
EC50 2 meas. best 6.7
Ki 1 meas.
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Neuronal acetylcholine receptor; alpha3/beta4 CHEMBL1907594 | IC50 | 7.0 | 5.98 | 100.0 | 5 |
| Neuronal acetylcholine receptor CHEMBL2094110 | EC50 | 6.7 | 6.7 | 200.0 | 1 |
| Neuronal acetylcholine receptor; alpha3/beta2 CHEMBL2109234 | IC50 | 6.55 | 6.55 | 280.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.52 | 5.785 | 300.0 | 2 |
| Neuronal acetylcholine receptor; alpha4/beta2 CHEMBL1907589 | IC50 | 6.22 | 6.22 | 600.0 | 1 |
| Acetylcholine receptor subunit alpha CHEMBL3097 | IC50 | 6.22 | 5.415 | 596.0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-7 CHEMBL2492 | IC50 | 5.75 | 5.33 | 1800.0 | 2 |
| Neuronal acetylcholine receptor; alpha2/beta4 CHEMBL2109230 | IC50 | 5.51 | 5.155 | 3100.0 | 2 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.22 | 4.63 | 6000.0 | 2 |
| Muscle-type nicotinic acetylcholine receptor CHEMBL2362997 | EC50 | 4.52 | 4.52 | 30000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 12109904 | 10.1021/jm011046l | Plasmodium falciparum | 4 |
| - | 10.1584/jpestics.20.49 | Acetylcholine receptor subunit alpha | 4 |
| 12109904 | 10.1021/jm011046l | No relevant target | 3 |
| 2002445 | 10.1021/jm00107a019 | Mus musculus | 3 |
| 2002445 | 10.1021/jm00107a019 | No relevant target | 3 |
| 16033252 | 10.1021/jm040219e | Neuronal acetylcholine receptor; alpha3/beta4 | 3 |
| 16033252 | 10.1021/jm040219e | Neuronal acetylcholine receptor; alpha4/beta4 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 2 |
| 22931300 | 10.1021/tx300075j | Liver microsomes | 2 |
| 22931300 | 10.1021/tx300075j | Cytochrome P450 3A4 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 16033252 | 10.1021/jm040219e | Neuronal acetylcholine receptor; alpha2/beta4 | 2 |
| - | 10.1584/jpestics.20.57 | Unchecked | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 4032427 | 10.1021/jm00147a021 | Neuronal acetylcholine receptor | 2 |
| 26948801 | 10.1016/j.drudis.2016.02.015 | Homo sapiens | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
Data from ChEMBL 36 via Core Engine